Amanote Research
Register
Sign In
Discovery and Evaluation of N-Cyclopropyl-2, 4-Difluoro-5-((2-(Pyridin-2-Ylamino)thiazol-5-Ylmethyl)amino)benzamide (BMS-605541), a Selective and Orally Efficacious Inhibitor of Vascular Endothelial Growth Factor Receptor-2
doi 10.1021/jm060347y.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
Frontiers in Pharmacology
Pharmacology
4-{4-Methyl-2-[(Methyl)(2-Methylphenyl)amino]-1,3-Thiazol-5-Yl}-N-(3-Methylphenyl)pyrimidin-2-Amine
Acta Crystallographica Section E Structure Reports Online
Discovery of 2-Hydroxy-N, N-Dimethyl-3-{2-[[(R)-1-(5-Methylfuran-2-Yl)propyl]amino]-3, 4-Dioxocyclobut-1-Enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist
2-(4-Fluorophenyl)-N-{4-[6-(4-Fluorophenyl)-2,3-Dihydroimidazo[2,1-B][1,3]thiazol-5-Yl]pyridin-2-Yl}acetamide
Acta Crystallographica Section E Structure Reports Online
Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)5-((4-((Morpholin-2-Ylmethyl)amino)-5-(Trifluoromethyl)pyridin-2-Yl)amino)pyrazine-2-Carbonitrile (CCT245737)
Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor
Cancer Science
Cancer Research
Medicine
Oncology
(Z)-2-(Benzo[d]thiazol-2-Ylamino)-5-(Substituted Benzylidene)thiazol-4(5h)-One Derivatives as Novel Tyrosinase Inhibitors
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Synthesis of N-Pyridin-2-Ylmethyl and N-Quinolin-2-Ylmethyl Substituted Ethane-1,2-Diamines
SynOpen
N,n-Bis(pyridin-2-Ylmethyl)cyclohexanamine
Acta Crystallographica Section E Structure Reports Online
